Back
Allogene Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
ALLO
Allogene Therapeutics
Last Price:
2.10
Seasonality Move:
6.59%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Allogene Therapeutics Stock Forecast
-
Is Allogene Therapeutics Stock Undervalued?
The current Allogene Therapeutics [ALLO] share price is $2.05. The Score for ALLO is 11, which is 78% below its historic median score of 50, and infers higher risk than normal. - ALLO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Allogene Therapeutics Stock Go Up Next Year?
Data Unavailable
Allogene Therapeutics Stock Rating
Data Unavailable
Allogene Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
allogene.com
52-Week Data
52-Week High:
5.78
52-Week Low:
2.01
Prediction Charts
Market Cap:
429.83M
Price in USD:
2.05
Volume:
2.44M
Beta:
0.92
Technical Analysis
SMA50:
2.72
SMA100:
2.67
SMA200:
3.14
52-Wk Change:
-31.44%
Stock Predictions
-
Is Allogene Therapeutics stock public?
Yes, Allogene Therapeutics is a publicly traded company. -
What is the Allogene Therapeutics stock quote today?
The Allogene Therapeutics stock price is 2.05 USD today. -
How to buy Allogene Therapeutics stock online?
You can buy Allogene Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 2.57 | 2.72 | 2.83 | 2.57 |
| Nov-4 | 2.73 | 3.00 | 3.03 | 2.66 |
| Nov-5 | 2.96 | 2.99 | 3.04 | 2.88 |
| Nov-6 | 3.05 | 3.22 | 3.29 | 2.99 |
| Nov-7 | 3.26 | 3.19 | 3.36 | 3.17 |
| Nov-8 | 3.24 | 3.08 | 3.26 | 2.95 |
| Nov-11 | 3.05 | 3.07 | 3.17 | 2.99 |
| Nov-12 | 3.01 | 2.84 | 3.05 | 2.83 |
| Nov-13 | 2.86 | 2.73 | 2.95 | 2.71 |
| Nov-14 | 2.72 | 2.46 | 2.75 | 2.46 |
| Nov-15 | 2.52 | 2.27 | 2.52 | 2.26 |
| Nov-18 | 2.30 | 2.15 | 2.32 | 2.14 |
| Nov-19 | 2.13 | 2.12 | 2.14 | 2.04 |
| Nov-20 | 2.11 | 2.05 | 2.14 | 1.99 |
Allogene Therapeutics Earnings
Data Unavailable
Allogene Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.06 per share.
* Allogene Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.